ArticleCancer2013

A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.

Matthew G Fury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.